Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study

Article Abstract:

Many HIV-infected women may develop anemia, according to a study of 2,056 HIV-infected women and 569 non-infected women. Thirty-seven percent of the HIV-infected women were anemic, compared to 17% of the HIV-negative women. Low CD4 T cell counts, high viral counts, and use of zidovudine were risk factors for anemia.

Causes of, Complications

---

Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: women's interagency HIV study.

Article Abstract:

The study was conducted to ascertain the impact of highly active antiretroviral therapy (HAART) on anemia and the relationship between anemia and overall survival in HIV-infected women. It was found that anemia is an independent risk factor for decreased survival among HIV-infected women and HAART therapy for as little as six months is associated with resolution of anemia.

Science & research, Care and treatment, Research, AIDS (Disease), AIDS research

---

Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the women's interagency HIV study

Article Abstract:

The factors and temporal trends associated with discontinuation of highly active antiretroviral therapy (HAART) among 936 HIV-infected women enrolled in the Women's Interagency HIV Study are characterized. A multivariate analysis of post-HAART initiation exposures found that high HIV RNA levels and high depressive symptom scores were associated with HAART discontinuation.

United States, Health aspects, Diagnosis, HIV infection

Similar abstracts:

• Abstracts: Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States
• Abstracts: Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection
• Abstracts: Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study)
• Abstracts: Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated durign early versus advanced states fo HIV disease
• Abstracts: Mode of delivery and postpartum morbidity among HIV-infected women: the Women and Infants Transmission Study. Multicenter review of protease inhibitors in 89 pregnancies

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.